Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Arizona Alzheimer's Consortium (AAC) FY20 | Grant | $13,615.00 | Research | Steven Rapcsak | Neurology | Arizona State University | 06/2020 |
| A Mixed Method to Identify Causes of Kidney Cancer Surgical Disparities in Arizona | Grant | $388,482.00 | Research | Ken Batai | Surgery | National Cancer Institute | 06/2020 |
| Tempe's BEST Project | Contract | $10,000.00 | Other Sponsored Activity | Wendy Parent-Johnson | Family and Community Medicine | City of Tempe, Arizona | 06/2020 |
| Ojo Con Su Vision Pilot Program | Contract | $15,000.00 | Other Sponsored Activity | Jesus Gonzalez Fagoaga | Public Hlth Pract & Trans Rsch | CommunicateHealth, Inc. | 06/2020 |
| Coronavirus Telehealth Resource Centers | Grant | $828,571.00 | Other Sponsored Activity | Ronald Weinstein | Arizona Telemedicine Program | Health Resources and Services Administration | 06/2020 |
| CARES Funding for Poison Centers | Grant | $39,532.00 | Other Sponsored Activity | Steven Dudley | Poison Control Center | Health Resources and Services Administration | 06/2020 |
| Student Aid for Field Epidemiology Response (SAFER) | Contract | $70,000.00 | Instruction | Kristen Pogreba Brown | Epidemiology and Biostatistics | Pima County Health Department | 06/2020 |
| Area Health Education Centers Program COVID | Grant | $95,455.00 | Instruction | Daniel Derksen | AZ Health Education Centers | Health Resources and Services Administration | 06/2020 |
| Zephyr Valve Registry (ZEVR) | Contract | $148,825.60 | Clinical Trial | Raed Alalawi | COM Phx Internal Medicine | Pulmonx Corporation | 06/2020 |
| Total Shoulder Arthroplasty Multi-Center Registry | Contract | $603,643.00 | Clinical Trial | Joshua Hustedt | COM Phx Orthopedics | Arthrex, Incorporated | 06/2020 |
| PRECISE: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization | Contract | $54,987.52 | Clinical Trial | Michael Morris | COM Phx Radiology | HeartFlow, Inc. | 06/2020 |
| Expanded Access Program Basis for the Treatment of Relapsed/Refractory Multiple Myeloma | Contract | $95,540.64 | Clinical Trial | Krisstina Gowin | Cancer Center Division | Glaxosmithkline | 06/2020 |
| Advancing Liver Therapeutic Approaches (ALTA). The ALTA Consortium Study Group for the management of portal hypertension - A 5-year longitudinal observation study of patients with cirrhosis .... | Contract | $26,687.50 | Clinical Trial | Michael Fallon | COM Phx Internal Medicine | Northwestern University | 06/2020 |
| A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired... | Contract | $593,373.00 | Clinical Trial | John Galgiani | Valley Fever Ctr for Excellnc | Duke University | 06/2020 |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients with COVID-19 Pneumonia | Contract | $3,236,387.50 | Clinical Trial | Sachin Chaudhary | Medicine | Syneos Health | 06/2020 |
| A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab | Contract | $208,612.70 | Clinical Trial | Gregory Woodhead | Cancer Center Division | Astrazeneca | 06/2020 |
| A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI... | Contract | $432,030.00 | Clinical Trial | Ramachandra Sista | COM Phx Internal Medicine | Covance, Incorporated | 06/2020 |
| A Phase II Trial of PET-Directed Therapy using AVD (Doxorubicin, Vinblastine, and Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin Plus Nivolumab, Foll | Contract | $40,100.00 | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Mayo Foundation for Medical Education and Research (Mayo Clinic) | 06/2020 |
| A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab or Cemiplimab in Patients with Advanced Solid Tumors | Contract | $157,802.00 | Clinical Trial | Montaser Shaheen | Cancer Center Division | Exicure, Inc. | 06/2020 |
| A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations | Contract | $643,931.75 | Clinical Trial | Hani Babiker | Cancer Center Division | Strategia Therapeutics | 06/2020 |
| A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair with the Edwards PASCAL Transcatheter ...... | Contract | $141,792.00 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | Edwards Lifesciences LLC | 06/2020 |
| Evaluation of Novel Nox4 Inhibitor on Alveolar Epithelial Cell Proliferation | Grant | $450.00 | Research Training | Louise Hecker | Medicine | Beta Beta Beta National Biological Honor Society | 05/2020 |
| Evaluating Efficacy of NADPH Oxidase-4 Inhibitors for Pro-Fibrotic Effects in Skin Fibrosis | Grant | $450.00 | Research Training | Louise Hecker | Medicine | Beta Beta Beta National Biological Honor Society | 05/2020 |
| Establishing an Animal Model to Evaluate Nox4 Inhibitors for Skin Fibrosis | Grant | $450.00 | Research Training | Louise Hecker | Medicine | Beta Beta Beta National Biological Honor Society | 05/2020 |
| Ryan White HIV/AIDS Program Part C EIS COVID19 Response | Grant | $92,250.00 | Research | Stephen Klotz | Medicine | Health Resources and Services Administration | 05/2020 |